Cargando…
Nothing lasts forever - a critical look at sustained remission
Remission is key to prevent progression of rheumatoid arthritis, but it is still rarely seen in clinical practice, not to speak of sustained remission, which is the best possible disease outcome of rheumatoid arthritis. New strategies and recommendations focus on achievement of remission, but it is...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446473/ https://www.ncbi.nlm.nih.gov/pubmed/22577881 http://dx.doi.org/10.1186/ar3795 |
_version_ | 1782243984117071872 |
---|---|
author | Aletaha, Daniel |
author_facet | Aletaha, Daniel |
author_sort | Aletaha, Daniel |
collection | PubMed |
description | Remission is key to prevent progression of rheumatoid arthritis, but it is still rarely seen in clinical practice, not to speak of sustained remission, which is the best possible disease outcome of rheumatoid arthritis. New strategies and recommendations focus on achievement of remission, but it is unclear how long remission can actually be maintained in clinical practice. A study by Prince and colleagues gives insights into this question, and raises some other questions for the future. |
format | Online Article Text |
id | pubmed-3446473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34464732012-11-09 Nothing lasts forever - a critical look at sustained remission Aletaha, Daniel Arthritis Res Ther Editorial Remission is key to prevent progression of rheumatoid arthritis, but it is still rarely seen in clinical practice, not to speak of sustained remission, which is the best possible disease outcome of rheumatoid arthritis. New strategies and recommendations focus on achievement of remission, but it is unclear how long remission can actually be maintained in clinical practice. A study by Prince and colleagues gives insights into this question, and raises some other questions for the future. BioMed Central 2012 2012-05-09 /pmc/articles/PMC3446473/ /pubmed/22577881 http://dx.doi.org/10.1186/ar3795 Text en Copyright ©2012 BioMed Central Ltd |
spellingShingle | Editorial Aletaha, Daniel Nothing lasts forever - a critical look at sustained remission |
title | Nothing lasts forever - a critical look at sustained remission |
title_full | Nothing lasts forever - a critical look at sustained remission |
title_fullStr | Nothing lasts forever - a critical look at sustained remission |
title_full_unstemmed | Nothing lasts forever - a critical look at sustained remission |
title_short | Nothing lasts forever - a critical look at sustained remission |
title_sort | nothing lasts forever - a critical look at sustained remission |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446473/ https://www.ncbi.nlm.nih.gov/pubmed/22577881 http://dx.doi.org/10.1186/ar3795 |
work_keys_str_mv | AT aletahadaniel nothinglastsforeveracriticallookatsustainedremission |